Finance committee  Yes.

Finance committee  There clearly always has to be a balance. There can be no later-stage projects if there is no early-stage research. Absolutely, there is an ecosystem of innovation in the health care system where you must have basic research, but hopefully, the best, most commercializable aspects

Finance committee  We've had a lot of success. It has been an excellent program for us to start with. We were one of the original cohorts of centres of excellence for commercialization and research. We were successfully renewed in that program, but we have outgrown those types of programs. In the

Finance committee  We think we've reached such a level that we are the national centre for drug development and commercialization. We have, over the past seven years, worked very hard to develop a national network. We feel that we have outgrown federal programs, and we really are now seeking a foun

Finance committee  Actually, it's only $140 million. It's really to leverage what we've already started, but really to establish CDRD firmly as a national organization with an expanded search team that we can really have people on the ground all across the country, and also to really invest in som

Finance committee  We've had quite a good record so far. We are a relatively new organization. We were initially funded in 2007 by the Province of B.C. and spent the first couple of years building labs and building up our team. Since then, we have a couple of spin-out companies. One is called Sitka

Finance committee  That's correct. We've kind of figured this out over the past several years of operating. We have a search team of very experienced scientists with industry focus who go to our partner institutions across Canada. All of the health research institutions are part of our network in

Finance committee  Good afternoon, ladies and gentlemen. On behalf of the Centre for Drug Research and Development, CDRD, and our commercialization vehicle, CDRD Ventures, I'd like to sincerely thank you for this opportunity to speak with you today. First, I will introduce our organization. Headq